SABRA HEALTH CARE REIT INC (SBRA) Forecast, Price Target & Analyst Ratings

NASDAQ:SBRA • US78573L1061

Current stock price

19.86 USD
+0.37 (+1.9%)
At close:
19.86 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SABRA HEALTH CARE REIT INC (SBRA).

Forecast Snapshot

Consensus Price Target

Price Target
$22.20
+ 11.81% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.17
Revenue Estimate
204.05M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
76.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$22.20
Upside
+ 11.81%
From current price of $19.86 to mean target of $22.20, Based on 20 analyst forecasts
Low
$20.20
Median
$22.44
High
$25.20

Price Target Revisions

1 Month
1.07%
3 Months
4.43%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for SBRA. The average price target is 22.2 USD. This implies a price increase of 11.81% is expected in the next year compared to the current price of 19.86.
The average price target has been revised upward by 4.43% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SBRA Current Analyst RatingSBRA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

SBRA Historical Analyst RatingsSBRA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
76.00%
SBRA was analyzed by 20 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about SBRA.
In the previous month the buy percentage consensus was at a similar level.
SBRA was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-26Wells FargoMaintains Overweight -> Overweight
2026-03-13Truist SecuritiesMaintains Hold -> Hold
2026-03-02ScotiaBankMaintains Sector Perform -> Sector Perform
2026-02-19UBSMaintains Neutral -> Neutral
2026-02-18CitizensMaintains Market Outperform -> Market Outperform
2026-02-18CitigroupMaintains Buy -> Buy
2026-02-17Cantor FitzgeraldMaintains Neutral -> Neutral
2026-01-20Truist SecuritiesMaintains Hold -> Hold
2025-11-25Wells FargoMaintains Overweight -> Overweight
2025-11-18UBSInitiate Neutral
2025-10-21Wells FargoMaintains Overweight -> Overweight
2025-10-01Cantor FitzgeraldInitiate Neutral
2025-09-03Truist SecuritiesMaintains Hold -> Hold
2025-08-27Wells FargoMaintains Overweight -> Overweight
2025-08-25BMO CapitalMaintains Market Perform -> Market Perform
2025-08-06JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-06-23ScotiaBankMaintains Sector Perform -> Sector Perform
2025-05-12ScotiaBankMaintains Sector Perform -> Sector Perform
2025-03-18Truist SecuritiesMaintains Hold -> Hold
2025-02-21Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-01-17Truist SecuritiesDowngrade Buy -> Hold
2025-01-07JMP SecuritiesUpgrade Market Perform -> Market Outperform
2024-12-05MizuhoDowngrade Outperform -> Neutral
2024-10-11ScotiaBankMaintains Sector Perform -> Sector Perform
2024-09-13CitigroupUpgrade Neutral -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.17
Revenue Estimate
204.05M
Revenue Q2Q
11.17%
EPS Q2Q
2.86%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
0.64%
Revenue (3 Months)
5.46%
EPS (1 Month)
-4.76%
EPS (3 Months)
-5.81%

Next Earnings Summary

SBRA is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.17 USD and the consensus revenue estimate is 204.05M USD.
The next earnings revenue estimate has been revised upward by 5.46% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
SBRA revenue by date.SBRA revenue by date.
647.514M
3.65%		703.235M
8.61%		774.632M
10.15%		833.97M
7.66%		909.64M
9.07%		991.6M
9.01%		1.071B
8.01%		1.309B
22.22%
EBITDA
YoY % growth
SBRA ebitda by date.SBRA ebitda by date.
404.606M
-4.21%		426.651M
5.45%		450.863M
5.67%		508.39M
12.76%		537.67M
5.76%		563.63M
4.83%		546.82M
-2.98%		N/A
EBIT
YoY % growth
SBRA ebit by date.SBRA ebit by date.
221.519M
-5.58%		257.028M
16.03%		263.867M
2.66%		296M
12.18%		389.69M
31.65%		356.52M
-8.51%		431.71M
21.09%		469.71M
8.80%
Operating Margin
SBRA operating margin by date.SBRA operating margin by date.
34.21%36.55%34.06%35.49%42.84%35.95%40.31%35.88%
EPS
YoY % growth
SBRA eps by date.SBRA eps by date.
0.05
114.71%		0.53
960.00%		0.64
20.75%		0.77
19.53%		0.81
5.33%		0.84
4.43%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.17
2.86%		0.19
-31.46%		0.19
110.47%		0.19
71.55%		0.20
12.77%		0.20
10.24%		0.20
7.69%		0.20
8.11%		0.20
3.45%		0.21
5.00%		0.22
10.00%		0.21
5.00%
Revenue
Q2Q % growth		204.05M
11.17%		208.49M
10.22%		212.69M
11.92%		216.81M
2.32%		225.69M
10.61%		229.4M
10.03%		234.32M
10.17%		238.95M
10.21%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		124.64M
12.23%		128.01M
-19.62%		130.57M
-33.09%		131.69M
-47.65%		132.04M
5.94%		134.32M
4.93%		135.71M
3.94%		135.47M
2.87%		138.41M
4.82%		141.31M
5.20%		142.68M
5.14%		141.24M
4.26%
EBIT
Q2Q % growth		83.382M
23.42%		87.105M
20.69%		89.527M
50.33%		90.678M
40.41%		79.344M
-4.84%		81.988M
-5.87%		84.119M
-6.04%		84.916M
-6.35%		87.73M
10.57%		91.82M
11.99%		93.177M
10.77%		91.351M
7.58%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SBRA Yearly Revenue VS EstimatesSBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SBRA Yearly EPS VS EstimatesSBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.55%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
9.97%
Revenue Next 5 Year
11.91%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
26.83%
EBIT Next 5 Year
18.62%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SABRA HEALTH CARE REIT INC / SBRA Forecast FAQ

What is the average price target for SABRA HEALTH CARE REIT INC (SBRA) stock?

20 analysts have analysed SBRA and the average price target is 22.2 USD. This implies a price increase of 11.81% is expected in the next year compared to the current price of 19.86.

Can you provide the upcoming earnings date for SABRA HEALTH CARE REIT INC?

SABRA HEALTH CARE REIT INC (SBRA) will report earnings on 2026-05-04.

Can you provide the consensus estimates for SABRA HEALTH CARE REIT INC next earnings?

The consensus EPS estimate for the next earnings of SABRA HEALTH CARE REIT INC (SBRA) is 0.17 USD and the consensus revenue estimate is 204.05M USD.

What is the expected long term growth rate for SABRA HEALTH CARE REIT INC (SBRA)?

The expected long term growth rate for SABRA HEALTH CARE REIT INC (SBRA) is 9.97%.